Formulation with simethicone, polyethylene glycol and hydroxyethylcellulose

GR1011186BActive Publication Date: 2026-05-07TSETI IOULIA

8 Cites 0 Cited by

Patent Information

Patent Timeline

10 Jun 2025

Application

GR20250100425

07 May 2026

Publication

GR1011186B

IPC: A61K31/80; A61K9/00; A61K9/16; A61K31/695; A61K31/717; A61K31/77; A61K47/10; A61K47/26; A61K47/38; A61P1/00

CPC: A61K31/80; A61P1/00; A61K31/695; A61K47/10; A61K47/38; A61K31/77; A61K31/717; A61K9/0095

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

A composition for oral administration containing simethicone, polyethylene glycol, hydroxyethylcellulose and one or more excipients.

Need to check novelty before this filing date? Find Prior Art

Polyethylene glycol (PEG 4000) in a contrast medium composition for echography
EP0955065A1
Compositions and solutions for colon cleansing
EP2931258B1
Nutritional supplement, suitable for oral administration, comprising lactoferrin, xyloglucan, proanthocyanidins and simethicone for the joint prevention of gastrointestinal and urinary tract infections
EP3820466B1
Heat stable antacid and antigas suspensions
US20030215525A1
Solid simethicone particles and dosage form thereof
US20190099379A1